The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
Contact phoneSparrow Clinical Research Institute 517.364.5760
Principal investigatorNam Cho, D.O.
Trial CategoryHeart & Vascular
Trial SubCategoryAtrial Fibrillation